Jeremy Grantham started to build up the position in Kezar Life Sciences in Q2 2020 and continued to invest until Q4 2020. Since then they sold 141 Thousand shares. The investor completely sold their stake between Q1 2021 and Q4 2021.
Avg closing price
Price range
Sold -70.3 Thousand shares
Q4 2021
Avg closing price
$11.29
Price range
$7.44
-
$16.72
Sold 41.3% shares (-49.5 Thousand shares)
Q3 2021
Avg closing price
$6.62
Price range
$4.85
-
$9.73
Sold 2.5% shares (-3.1 Thousand shares)
Q2 2021
Avg closing price
$5.68
Price range
$4.93
-
$6.46
Sold 12.9% shares (-18.3 Thousand shares)
Q1 2021
Avg closing price
$5.85
Price range
$5.24
-
$6.99
Increased shares by 110.4% (+74.1 Thousand shares)
Q4 2020
Avg closing price
$5.56
Price range
$4.77
-
$6.58
Increased shares by 319.4% (+51.1 Thousand shares)
Q3 2020